RTHM
@RTHM_Health
RTHM connects you with a digital care team specializing in Long COVID and ME/CFS that provides access to a range of therapies based on the latest research.
In our latest webinar, Stanford professor @SnyderShot, Director of the Center for Genomics and Personalized Medicine, shares how artificial intelligence is being used to analyze data from wearables and blood microsamples. This technology may be able to help identify subtypes of…
⁉️📣 Calling those with #LongCOVID, #MECFS, or #POTS who have tried Guanfacine — how did your symptoms change overall? If you experienced improvements or worsening, let us know which symptoms changed for you in the comments. Please share 🙏 @patientled @ahandvanish…
Some of the most prominent voices in AI have claimed it might cure all diseases within the next decade. In Can AI Crack Long COVID?, @tomrosenblatt2, CEO of Being and a chronic illness patient himself, reflects on whether that’s hype or possibility, and lands somewhere in…
Have you tried ketotifen for Long COVID, ME/CFS, or MCAS-related symptoms? According to real world data from patients using ketotifen through RTHM Direct, 58.5% of RTHM Direct patients *who were prescribed ketotifen* reported noticeable improvements in their symptoms—and 80% of…
We're hosting a Patient-Led Research Fund (PLRF) webinar on July 9, 1–4:30PM ET! Hear results from 10 PLRF-funded biomedical studies (on microclots, T cell exhaustion, trials, & more), all selected by a panel of patient-researchers. Register: us02web.zoom.us/webinar/regist… #LongCOVID
Could AI help crack your Long COVID? @idsimon, former Director of the U.S. Department of Health and Human Services’ Office of Long COVID Research and Practice, shares how AI may be able to identify off-label drugs already on the market to treat Long COVID. These insights could…